Search Within

Dmitriy Zamarin

  1. "2017"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Department of Medicine (11)
  2. GDMT, Medicine (11)
  3. Gynecologic Medicine Service (11)
  4. Gynecology Disease Management Team (11)
  5. Solid Tumor Oncology Division (11)
  6. GSK Faculty (7)

More Groups

People
  1. Carol Aghajanian (7)
  2. Jacob Ricca (6)
  3. Jason Konner (6)
  4. Jedd Wolchok (6)
  5. Alexandra Snyder Charen (5)
  6. Taha Merghoub (5)

More People

Years
  1. 2017 (11)
Publications
  1. Journal of Clinical Oncology (4)
  2. Annals of Oncology (1)
  3. Cancer Immunology Research (1)
  4. Cell (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Methods in Molecular Biology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Amer Assoc Advancement Science (1)
  3. American Association for Cancer Research (1)
  4. Biomed Central Ltd (1)
  5. Cell Press (1)
  6. Humana Press Inc (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
    Journal Article

    Dai, P.; Wang, W.; Yang, N.; Serna-Tamayo, C.; Ricca, J. M.; Zamarin, D.; Shuman, S.; Merghoub, T.; Wolchok, J. D.; Deng, L.
    Science Immunology (2017)

    Fulltext@MSK | Save
  • Early clinical progression in patients with gynecologic malignancies receiving immunomodulatory antibody therapy
    Meeting Abstract

    Zamarin, D.; Martin, M.; Zecca, N.; Iasonos, A.; Zhou, Q.; Aghajanian, C.; Sabbatini, P.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of intraperitoneal (IP) cisplatin, IV/IP paclitaxel, IV bevacizumab, and oral olaparib for newly diagnosed adenxal carcinoma
    Meeting Abstract

    Konner, J. A.; Boucicaut, N. N.; O'Cearbhaill, R. E.; Zamarin, D.; Makker, V.; Sabbatini, P.; Tew, W. P.; Cadoo, K. A.; Grisham, R. N.; Aghajanian, C.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of enzalutamide in patients with androgen receptor positive (AR+) ovarian, primary peritoneal or fallopian tube cancer and one, two, or three prior therapies
    Meeting Abstract

    Grisham, R. N.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; McGrath, S. P.; O'Cearbhaill, R. E.; Sabbatini, P.; Tew, W. P.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Somatic mutations in homologous recombination pathway genes in ovarian cancer
    Meeting Abstract

    Aghajanian, C.; DeLair, D.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Makker, V.; O'Cearbhaill, R. E.; Sabbatini, P.; Soumerai, T.; Charen, A. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Upregulation of PD-L1 in tumor microenvironment is a resistance mechanism for oncolytic virus immunotherapy
    Meeting Abstract

    Zamarin, D.; Ricca, J.; Oseledchyk, A.; Gigoux, M.; Merghoub, T.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: A Surveillance, Epidemiology, and End Results cohort study, 2000-2013
    Journal Article

    Oseledchyk, A.; Leitao, M. M. Jr; Konner, J.; O'Cearbhaill, R. E.; Zamarin, D.; Sonoda, Y.; Gardner, G. J.; Roche, K. L.; Aghajanian, C. A.; Grisham, R. N.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Heterogeneous fates of metastatic lesions linked to immune escape in an ovarian cancer patient
    Meeting Abstract

    Jiménez-Sánchez, A.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; Ricca, J.; Zamarin, D.; more...
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
    Journal Article

    Jiménez-Sánchez, A.; Memon, D.; Pourpe, S.; Veeraraghavan, H.; Li, Y.; Vargas, H. A.; Gill, M. B.; Park, K. J.; Zivanovic, O.; Konner, J.; more...
    Cell (2017)

    Fulltext@MSK | Save
  • Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
    Journal Article

    Zamarin, D.; Holmgaard, R. B.; Ricca, J.; Plitt, T.; Palese, P.; Sharma, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
    Nature Communications (2017)

    Fulltext@MSK | Save